Compounds of the formula (I), in which X1, X2, X3, X4, X5, R1, R2, R3, R3', R4, R6 and R7 have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.